呼吸内科患者多药耐药菌感染的分析

Multidrug-resistant bacteria infections in patients of respiratory medicine department

目的探究呼吸内科患者多药耐药菌的感染情况及其相关的对策,从而为临床中预防和控制多药耐药菌的感染提供参考依据。方法采取回顾性方法对医院2010年2月-2011年2月收治的120例呼吸内科多药耐药菌感染患者的临床资料和病原菌感染情况进行分析,并制定针对性的护理策略。结果通过对120例呼吸内科患者的临床资料分析,结果显示多药耐药菌感染的发生与患者的年龄、住院时间和侵入性操作及抗菌药物合理使用相关(P<0.05);共培养出病原菌130株,依次为金黄色葡萄球菌、大肠埃希菌、铜绿假单胞菌、肺炎克雷伯菌和鲍氏不动杆菌,分别占35.4%、26.2%、15.4%、13.0%、10.0%。结论在呼吸内科患者的多药耐药菌感染中,应加强对患者的监测,规范用药,并严格执行隔离措施,从而有效预防多药耐药菌的感染。

OBJECTIVE To explore the status of multidrug-resistant bacteria infections in the patients of respiratory medicine department and put forward corresponding nursing measures so as to provide basis for the prevention and control of the multidrug-resistant bacteria infections.METHODS A total of 120 cases of patients with multidrugresistant bacteria infections,who were treated in the respiratory medicine department from Feb 2010 to Feb 2011,were enrolled in the study,then the clinical data of the participants and the incidence of infections were retrospectively analyzed,and the targeted nursing interventions were put forward.RESULTS Through the analysis of the clinical data of the 120 patients,it was suggested that the incidence of the multidrug-resistant bacteria infections was related to the age,length of hospital,invasive operation,and use of antibiotics（P0.05）.A total of 130 strains of pathogens were isolated,among which the Staphylococcus aureus,Escherichia coli,Pseudomonas aeruginosa,Klebsiella pneumoniae,and Acinetobacter baumannii accounted for 35.4%,26.2%,15.4%,13.0%,and 10.0%,respectively.CONCLUSION For the patients with multidrug-resistant bacteria infections in the respiratory medicine department,it is necessary to strengthen the monitoring of the patients,reasonably use antibiotics,and rigidly execute the isolation measures so as to effectively prevent the multidrugresistant bacteria infections.